Show notes
In this episode Ole Schmiedel discusses Mounjaro, a new weight loss drug, with a focus on its mechanism of action, practical use, side effects, nutritional considerations, and long-term safety. The conversation provides insights into how Mounjaro differs from previous GLP-1 receptor agonists, expected weight loss outcomes, and the importance of monitoring patients while on the medication.
Website: goodfellowunit.org
